{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:16:01Z","timestamp":1784592961735,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.mehy.2020.110168","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T11:53:11Z","timestamp":1596801191000},"page":"110168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5\/14"],"prefix":"10.1016","volume":"144","author":[{"given":"Simon H.","family":"Murch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110168_b0005","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin- converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit Care"},{"issue":"20","key":"10.1016\/j.mehy.2020.110168_b0010","first-page":"30234","article-title":"Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis","volume":"S0163\u20134453","author":"Zheng","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.mehy.2020.110168_b0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-981-15-1580-4_8","article-title":"Siglecs at the Host-Pathogen Interface","volume":"1204","author":"Chang","year":"2020","journal-title":"Adv Exp Med Bio"},{"key":"10.1016\/j.mehy.2020.110168_b0020","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1093\/glycob\/cwj008","article-title":"Siglecs\u2013the major subfamily of I-type lectins","volume":"16","author":"Varki","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.mehy.2020.110168_b0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.dci.2018.05.008","article-title":"Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins","volume":"86","author":"Bornh\u00f6fft","year":"2018","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.mehy.2020.110168_b0030","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1096\/fj.13-241497","article-title":"Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates","volume":"28","author":"Padler-Karavani","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2020.110168_b0035","doi-asserted-by":"crossref","first-page":"13320","DOI":"10.1523\/JNEUROSCI.1224-13.2013","article-title":"CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing","volume":"33","author":"Malik","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2020.110168_b0040","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1084\/jem.20131853","article-title":"Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus","volume":"211","author":"Ali","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2020.110168_b0045","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.275.12.8625","article-title":"New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope.J","volume":"275","author":"Brinkman-Van der Linden","year":"2000","journal-title":"Biol Chem"},{"key":"10.1016\/j.mehy.2020.110168_b0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2020.110168_b0055","doi-asserted-by":"crossref","unstructured":"Shajahan A, Supekar NT, Gleinich AS, Azadi P. Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2. Glycobiology 2020 May 4. pii: cwaa042. doi: 10.1093\/glycob\/cwaa042.","DOI":"10.1101\/2020.04.01.020966"},{"key":"10.1016\/j.mehy.2020.110168_b0060","doi-asserted-by":"crossref","unstructured":"Watanabe Y, Allen JD, Wrapp D, McLellan JS, Crispin M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science 2020 May 4. pii: eabb9983. doi: 10.1126\/science.abb9983.","DOI":"10.1101\/2020.03.26.010322"},{"key":"10.1016\/j.mehy.2020.110168_b0065","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1007\/s00018-004-4257-y","article-title":"The SARS-CoV S glycoprotein","volume":"61","author":"Xiao","year":"2004","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"10.1016\/j.mehy.2020.110168_b0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fimmu.2020.00211","article-title":"NLRP3 Inflammasome-A Key Player in Antiviral Responses","volume":"18","author":"Zhao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2020.110168_b0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.chom.2010.06.005","article-title":"Inflammasome inhibition as a pathogenic stealth mechanism","volume":"8","author":"Taxman","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mehy.2020.110168_b0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000504323","article-title":"Siglec-14 Enhances NLRP3-Inflammasome Activation in Macrophages","volume":"12","author":"Tsai","year":"2020","journal-title":"J Innate Immun"},{"key":"10.1016\/j.mehy.2020.110168_b0085","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/glycob\/cwp052","article-title":"Deletion polymorphism of SIGLEC14 and its functional implications","volume":"19","author":"Yamanaka","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.mehy.2020.110168_b0090","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1007\/s00018-013-1311-7","article-title":"Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation","volume":"70","author":"Angata","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.mehy.2020.110168_b0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tube.2017.02.005","article-title":"The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes","volume":"104","author":"Graustein","year":"2017","journal-title":"Tuberculosis"},{"key":"10.1016\/j.mehy.2020.110168_b0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tips.2018.10.008","article-title":"MDSC; the Most Important Cell You Have Never Heard Of","volume":"40","author":"Tesi","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mehy.2020.110168_b0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clim.2012.06.003","article-title":"On the armament and appearances of human myeloid-derived suppressor cells","volume":"144","author":"Poschke","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.mehy.2020.110168_b0110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1189\/jlb.0912461","article-title":"Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer","volume":"93","author":"Verschoor","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.mehy.2020.110168_b0115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.imlet.2017.07.003","article-title":"Myeloid-derived suppressor cells modulate B-cell responses","volume":"188","author":"Lelis","year":"2017","journal-title":"Immunol Lett"},{"key":"10.1016\/j.mehy.2020.110168_b0120","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00262-020-02523-w","article-title":"Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma","volume":"69","author":"Dar","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.mehy.2020.110168_b0125","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3892\/mmr.2014.2927","article-title":"Increased monocytic CD14+HLADRlow\/- myeloid-derived suppressor cells in obesity","volume":"11","author":"Bao","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.mehy.2020.110168_b0130","doi-asserted-by":"crossref","first-page":"1568457","DOI":"10.1155\/2019\/1568457","article-title":"Myeloid-Derived Suppressor Cells Show Different Frequencies in Diabetics and Subjects with Arterial Hypertension","volume":"2019","author":"Fern\u00e1ndez-Ruiz","year":"2019","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.mehy.2020.110168_b0135","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.rmed.2013.08.002","article-title":"Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells","volume":"107","author":"Scrimini","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.mehy.2020.110168_b0140","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.mehy.2020.110168_b0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13054-020-02857-y","article-title":"Delayed persistence of elevated monocytic MDSC associates with deleterious outcomes in septic shock: a retrospective cohort study","volume":"24","author":"Waeckel","year":"2020","journal-title":"Crit Care"},{"issue":"992\u20131000","key":"10.1016\/j.mehy.2020.110168_b0150","article-title":"Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mehy.2020.110168_b0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clim.2015.02.001","article-title":"Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiation","volume":"157","author":"Zhang","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.mehy.2020.110168_b0160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/annrheumdis-2014-205508","article-title":"Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis","volume":"75","author":"Guo","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mehy.2020.110168_b0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5217\/ir.2015.13.2.105","article-title":"Myeloid-derived suppressor cells in inflammatory bowel disease","volume":"13","author":"Kim","year":"2015","journal-title":"Intest Res"},{"key":"10.1016\/j.mehy.2020.110168_b0170","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1021\/acschemneuro.0c00201","article-title":"Neurological Insights of COVID-19 Pandemic","volume":"11","author":"Das","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.mehy.2020.110168_b0175","doi-asserted-by":"crossref","first-page":"11272","DOI":"10.1038\/s41598-017-11820-x","article-title":"Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.mehy.2020.110168_b0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaut.2019.03.008","article-title":"Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome","volume":"100","author":"Lee","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.mehy.2020.110168_b0185","doi-asserted-by":"crossref","unstructured":"Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G, et al. Intensive care admissions of children withpaediatricinflammatory multisystemsyndrometemporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.Lancet Child Adolesc Health 2020 Jul 9: S2352-4642(20)30215-7.","DOI":"10.1016\/S2352-4642(20)30215-7"},{"key":"10.1016\/j.mehy.2020.110168_b0190","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem Inflammatory Syndrome in U.S. Children and Adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.110168_b0195","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41591-020-0817-4","article-title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding","volume":"26","author":"Xu","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2020.110168_b0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 productively infects human gut enterocytes","volume":"369","author":"Lamers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.mehy.2020.110168_b0205","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0003489418812902","article-title":"Myeloid-Derived Suppressor Cells and Costimulatory Molecules in Children With Allergic Rhinitis","volume":"128","author":"Zahran","year":"2019","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.mehy.2020.110168_b0210","article-title":"Peripheral blood MDSCs, IL-10 and IL-12 in children with asthma and their importance in asthma development","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2020.110168_b0215","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.4049\/jimmunol.177.4.2088","article-title":"TLR7 ligands induce higher IFN-alpha production in females","volume":"177","author":"Bergh\u00f6fer","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2020.110168_b0220","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.3389\/fimmu.2018.03167","article-title":"Sex and Pubertal Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone Concentration","volume":"9","author":"Webb","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2020.110168_b0225","doi-asserted-by":"crossref","unstructured":"Bordoni V, Sacchi A, Cimini E, Notari S, Grassi G, Tartaglia E, et al. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19. Clin Infect Dis 2020 May 15. pii: ciaa577. doi: 10.1093\/cid\/ciaa577.","DOI":"10.1093\/cid\/ciaa577"},{"key":"10.1016\/j.mehy.2020.110168_b0230","first-page":"1","article-title":"Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)","volume":"8","author":"Agrati","year":"2020","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.mehy.2020.110168_b0235","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1186\/s12879-019-4574-2","article-title":"The clinical significance of myeloid-derived suppressor cells in dengue fever patients","volume":"19","author":"Guo","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mehy.2020.110168_b0240","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib","volume":"53","author":"Wu","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.mehy.2020.110168_b0245","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720313347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720313347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:31:47Z","timestamp":1759692707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720313347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":49,"alternative-id":["S0306987720313347"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110168","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5\/14","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110168"}}